Valuation: Illumina, Inc.

Market Cap 28.43B 24.56B 23.1B 21B 39.5B 2,724B 40.07B 271B 106B 1,362B 107B 104B 4,538B P/E 2026 *
38x
P/E 2027 * 32.2x
Enterprise Value 28.68B 24.77B 23.3B 21.18B 39.84B 2,748B 40.42B 273B 107B 1,374B 108B 105B 4,577B EV / Sales 2026 *
6.2x
EV / Sales 2027 * 5.64x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.51%
1 week-2.36%
Current month-8.20%
1 month+0.88%
3 months+33.06%
6 months+56.79%
Current year+43.56%
1 week 187.44
Extreme 187.44
194.5
1 month 178.88
Extreme 178.88
207
Current year 112.65
Extreme 112.65
207
1 year 88
Extreme 88
207
3 years 68.7
Extreme 68.7
207
5 years 68.7
Extreme 68.7
492.29
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer - 01/02/2026
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
05/08/26
Corvex Management LP
SellCompany -283,269 0.1872%
05/08/26 Free

Executive/Senior Manager

15,011 0.0099%
04/08/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.51%-2.36%+87.30%+12.60% 28.43B
+0.60%-2.64%+20.82%+10.64% 218B
-1.51%-3.79%-4.51%-20.62% 140B
+0.22%-2.50%-18.72%+36.80% 138B
-1.87%-1.41%-51.02%+0.56% 73.14B
+0.19%-2.86%+16.19%+18.80% 52.44B
-0.37%+0.69%-17.58%-13.59% 50.85B
-0.01%-0.70%+25.64%+24.48% 41.92B
-1.59%-3.31%+38.65%+48.61% 39.42B
+0.36%-0.16%-0.74%+6.25% 32.81B
Average -0.64%-1.85%+9.60%+12.45% 81.53B
Weighted average by Cap. -0.39%-2.30%+3.18%+10.24%

Financials

2026 *2027 *
Net sales 4.62B 3.99B 3.76B 3.42B 6.42B 443B 6.52B 44.08B 17.28B 222B 17.36B 16.99B 738B 4.91B 4.24B 3.99B 3.63B 6.82B 471B 6.92B 46.81B 18.35B 235B 18.44B 18.04B 784B
Net income 760M 657M 618M 562M 1.06B 72.85B 1.07B 7.25B 2.84B 36.44B 2.85B 2.79B 121B 891M 770M 724M 658M 1.24B 85.39B 1.26B 8.5B 3.33B 42.71B 3.35B 3.27B 142B
Net Debt 246M 212M 200M 182M 342M 23.57B 347M 2.35B 919M 11.79B 924M 904M 39.27B -729M -630M -592M -538M -1.01B -69.85B -1.03B -6.95B -2.72B -34.93B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
18/08/26 $188.29 -2.51% 1,192,959
17/08/26 $193.14 +1.18% 995,956
14/08/26 $190.89 -0.91% 993,080
13/08/26 $192.64 -0.14% 1,061,432
12/08/26 $192.91 +0.04% 1,256,641
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
188.29USD
Average target price
198.89USD
Spread / Average Target
+5.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock